{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:30:19Z","timestamp":1772026219703,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20151372"],"award-info":[{"award-number":["BK20151372"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470206"],"award-info":[{"award-number":["81470206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pandemic 2009 influenza A H1N1 virus is associated with significant mortality. Targeting S1PR1, which is known to modulate the immune response, provides protection against pathogenic influenza virus. The functional role and molecular mechanism of S1PR1 were analysed by generating inducible endothelial cell-specific S1PR1 knockout mice and assessing the therapeutic efficacy of the selective S1PR1 agonist CYM5442 against acute lung injury (ALI) induced by the 2009 influenza A H1N1 virus. Immune-mediated pulmonary injury is aggravated by the absence of endothelial S1PR1 and alleviated by treatment with CYM-5442, suggesting a protective function of S1PR1 signaling during H1N1 infection. S1PR1 signaling does not affect viral clearance in mice infected with influenza. Mechanistically, the MAPK and NF-kB signaling pathways are involved in the ALI mediated by S1PR1 in infected mice. Combined administration of the S1PR1 agonist CYM-5442 and the antiviral drug oseltamivir provides maximum protection from ALI. Our current study provides insight into the molecular mechanism of S1PR1 mediating the ALI induced by H1N1 infection and indicates that the combination of S1PR1 agonist with antiviral drug could potentially be used as a therapeutic remedy for future H1N1 virus pandemics.<\/jats:p>","DOI":"10.1038\/s41598-019-41760-7","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T16:49:55Z","timestamp":1553705395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["RETRACTED ARTICLE: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus"],"prefix":"10.1038","volume":"9","author":[{"given":"Jiangnan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"41760_CR1","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1056\/NEJMoa0903810","volume":"360","author":"AVIT Novel Swine-Origin Influenza","year":"2009","unstructured":"Novel Swine-Origin Influenza, A. V. I. T. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England journal of medicine 360, 2605\u20132615, https:\/\/doi.org\/10.1056\/NEJMoa0903810 (2009).","journal-title":"The New England journal of medicine"},{"key":"41760_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1473-3099(12)70121-4","volume":"12","author":"FS Dawood","year":"2012","unstructured":"Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12, 687\u2013695, https:\/\/doi.org\/10.1016\/S1473-3099(12)70121-4 (2012).","journal-title":"Lancet Infect Dis"},{"key":"41760_CR3","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","volume":"146","author":"JR Teijaro","year":"2011","unstructured":"Teijaro, J. R. et al. Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection. Cell 146, 980\u2013991, https:\/\/doi.org\/10.1016\/j.cell.2011.08.015 (2011).","journal-title":"Cell"},{"key":"41760_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12026-011-8240-z","volume":"51","author":"KB Walsh","year":"2011","unstructured":"Walsh, K. B., Teijaro, J. R., Rosen, H. & Oldstone, M. B. Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm. Immunologic research 51, 15\u201325, https:\/\/doi.org\/10.1007\/s12026-011-8240-z (2011).","journal-title":"Immunologic research"},{"key":"41760_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nature05495","volume":"445","author":"D Kobasa","year":"2007","unstructured":"Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319\u2013323, https:\/\/doi.org\/10.1038\/nature05495 (2007).","journal-title":"Nature"},{"key":"41760_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.virol.2014.01.003","volume":"452\u2013453","author":"JR Teijaro","year":"2014","unstructured":"Teijaro, J. R. et al. Protection of ferrets from pulmonary injury due to H1N1 2009 influenza virus infection: immunopathology tractable by sphingosine-1-phosphate 1 receptor agonist therapy. Virology 452\u2013453, 152\u2013157, https:\/\/doi.org\/10.1016\/j.virol.2014.01.003 (2014).","journal-title":"Virology"},{"key":"41760_CR7","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1073\/pnas.1107024108","volume":"108","author":"KB Walsh","year":"2011","unstructured":"Walsh, K. B. et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proceedings of the National Academy of Sciences of the United States of America 108, 12018\u201312023, https:\/\/doi.org\/10.1073\/pnas.1107024108 (2011).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"41760_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1388-1981(00)00042-1","volume":"1485","author":"A Huwiler","year":"2000","unstructured":"Huwiler, A., Kolter, T., Pfeilschifter, J. & Sandhoff, K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Bba-Mol Cell Biol L 1485, 63\u201399, https:\/\/doi.org\/10.1016\/S1388-1981(00)00042-1 (2000).","journal-title":"Bba-Mol Cell Biol L"},{"key":"41760_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1096\/fj.06-7433com","volume":"21","author":"P Hanel","year":"2007","unstructured":"Hanel, P., Andreani, P. & Graler, M. H. Erythrocytes store and release sphingosine 1-phosphate in blood. Faseb J 21, 1202\u20131209, https:\/\/doi.org\/10.1096\/fj.06-7433com (2007).","journal-title":"Faseb J"},{"key":"41760_CR10","doi-asserted-by":"publisher","first-page":"L258","DOI":"10.1152\/ajplung.00311.2002","volume":"285","author":"KL Schaphorst","year":"2003","unstructured":"Schaphorst, K. L. et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. American journal of physiology. Lung cellular and molecular physiology 285, L258\u2013267, https:\/\/doi.org\/10.1152\/ajplung.00311.2002 (2003).","journal-title":"American journal of physiology. Lung cellular and molecular physiology"},{"key":"41760_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/Circresaha.107.165845","volume":"102","author":"K Venkataraman","year":"2008","unstructured":"Venkataraman, K. et al. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circulation research 102, 669\u2013676, https:\/\/doi.org\/10.1161\/Circresaha.107.165845 (2008).","journal-title":"Circulation research"},{"key":"41760_CR12","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1073\/pnas.0812689106","volume":"106","author":"D Marsolais","year":"2009","unstructured":"Marsolais, D. et al. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proceedings of the National Academy of Sciences of the United States of America 106, 1560\u20131565, https:\/\/doi.org\/10.1073\/pnas.0812689106 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"41760_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.78.072407.103733","volume":"78","author":"H Rosen","year":"2009","unstructured":"Rosen, H., Gonzalez-Cabrera, P. J., Sanna, M. G. & Brown, S. Sphingosine 1-phosphate receptor signaling. Annual review of biochemistry 78, 743\u2013768, https:\/\/doi.org\/10.1146\/annurev.biochem.78.072407.103733 (2009).","journal-title":"Annual review of biochemistry"},{"key":"41760_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.it.2007.01.007","volume":"28","author":"H Rosen","year":"2007","unstructured":"Rosen, H., Sanna, M. G., Cahalan, S. M. & Gonzalez-Cabrera, P. J. Tipping the gatekeeper: S1P regulation of endothelial barrier function. Trends in immunology 28, 102\u2013107, https:\/\/doi.org\/10.1016\/j.it.2007.01.007 (2007).","journal-title":"Trends in immunology"},{"key":"41760_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","volume":"82","author":"H Rosen","year":"2013","unstructured":"Rosen, H., Stevens, R. C., Hanson, M., Roberts, E. & Oldstone, M. B. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annual review of biochemistry 82, 637\u2013662, https:\/\/doi.org\/10.1146\/annurev-biochem-062411-130916 (2013).","journal-title":"Annual review of biochemistry"},{"key":"41760_CR16","doi-asserted-by":"publisher","first-page":"e0175188","DOI":"10.1371\/journal.pone.0175188","volume":"12","author":"H Jiang","year":"2017","unstructured":"Jiang, H., Shen, S. M., Yin, J., Zhang, P. P. & Shi, Y. Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses. PloS one 12, e0175188, https:\/\/doi.org\/10.1371\/journal.pone.0175188 (2017).","journal-title":"PloS one"},{"key":"41760_CR17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1172\/Jci10905","volume":"106","author":"YJ Liu","year":"2000","unstructured":"Liu, Y. J. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106, 951\u2013961, https:\/\/doi.org\/10.1172\/Jci10905 (2000).","journal-title":"J Clin Invest"},{"key":"41760_CR18","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1182\/blood-2003-02-0460","volume":"102","author":"ML Allende","year":"2003","unstructured":"Allende, M. L., Yamashita, T. & Proia, R. L. G-protein-coupled receptor S1P(1) acts within endothelial cells to regulate vascular maturation. Blood 102, 3665\u20133667 (2003).","journal-title":"Blood"},{"key":"41760_CR19","doi-asserted-by":"publisher","first-page":"e30328","DOI":"10.1371\/journal.pone.0030328","volume":"7","author":"W Gao","year":"2012","unstructured":"Gao, W. et al. Distinct regulation of host responses by ERK and JNK MAP kinases in swine macrophages infected with pandemic (H1N1) 2009 influenza virus. PloS one 7, e30328, https:\/\/doi.org\/10.1371\/journal.pone.0030328 (2012).","journal-title":"PloS one"},{"key":"41760_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/gene.10117","volume":"33","author":"A Forde","year":"2002","unstructured":"Forde, A., Constien, R., Grone, H. J., Hammerling, G. & Arnold, B. Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements. Genesis 33, 191\u2013197, https:\/\/doi.org\/10.1002\/gene.10117 (2002).","journal-title":"Genesis"},{"key":"41760_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/jama.2010.1277","volume":"304","author":"EA Belongia","year":"2010","unstructured":"Belongia, E. A. et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008\u20132009 (H1N1), and 2007\u20132008 (H3N2) infections. Jama 304, 1091\u20131098, https:\/\/doi.org\/10.1001\/jama.2010.1277 (2010).","journal-title":"Jama"},{"key":"41760_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1086\/650581","volume":"50","author":"KK To","year":"2010","unstructured":"To, K. K. et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 50, 850\u2013859, https:\/\/doi.org\/10.1086\/650581 (2010).","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"41760_CR23","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.1128\/JVI.00804-10","volume":"84","author":"D Marchant","year":"2010","unstructured":"Marchant, D. et al. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. Journal of virology 84, 11359\u201311373, https:\/\/doi.org\/10.1128\/JVI.00804-10 (2010).","journal-title":"Journal of virology"},{"key":"41760_CR24","doi-asserted-by":"crossref","unstructured":"Hui, K. P. et al. Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK. Journal of immunology 182, 1088\u20131098 (2009).","DOI":"10.4049\/jimmunol.182.2.1088"},{"key":"41760_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"RG Baker","year":"2011","unstructured":"Baker, R. G., Hayden, M. S. & Ghosh, S. NF-kappaB, inflammation, and metabolic disease. Cell metabolism 13, 11\u201322, https:\/\/doi.org\/10.1016\/j.cmet.2010.12.008 (2011).","journal-title":"Cell metabolism"},{"key":"41760_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","volume":"132","author":"MS Hayden","year":"2008","unstructured":"Hayden, M. S. & Ghosh, S. Shared principles in NF-kappaB signaling. Cell 132, 344\u2013362, https:\/\/doi.org\/10.1016\/j.cell.2008.01.020 (2008).","journal-title":"Cell"},{"key":"41760_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley, K., Laudanna, C., Cybulsky, M. I. & Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nature reviews. Immunology 7, 678\u2013689, https:\/\/doi.org\/10.1038\/nri2156 (2007).","journal-title":"Nature reviews. Immunology"},{"key":"41760_CR28","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.immuni.2014.10.008","volume":"41","author":"S Nourshargh","year":"2014","unstructured":"Nourshargh, S. & Alon, R. Leukocyte Migration into Inflamed Tissues. Immunity 41, 694\u2013707, https:\/\/doi.org\/10.1016\/j.immuni.2014.10.008 (2014).","journal-title":"Immunity"},{"key":"41760_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/sj.icb.7100026","volume":"85","author":"NL La Gruta","year":"2007","unstructured":"La Gruta, N. L., Kedzierska, K., Stambas, J. & Doherty, P. C. A question of self-preservation: immunopathology in influenza virus infection. Immunology and cell biology 85, 85\u201392, https:\/\/doi.org\/10.1038\/sj.icb.7100026 (2007).","journal-title":"Immunology and cell biology"},{"key":"41760_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.mvr.2008.09.005","volume":"77","author":"L Wang","year":"2009","unstructured":"Wang, L. & Dudek, S. M. Regulation of vascular permeability by sphingosine 1-phosphate. Microvascular research 77, 39\u201345, https:\/\/doi.org\/10.1016\/j.mvr.2008.09.005 (2009).","journal-title":"Microvascular research"},{"key":"41760_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1165\/rcmb.2009-0223OC","volume":"43","author":"S Sammani","year":"2010","unstructured":"Sammani, S. et al. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. American journal of respiratory cell and molecular biology 43, 394\u2013402, https:\/\/doi.org\/10.1165\/rcmb.2009-0223OC (2010).","journal-title":"American journal of respiratory cell and molecular biology"},{"key":"41760_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/01.ATV.0000154360.36106.d9","volume":"25","author":"V Krump-Konvalinkova","year":"2005","unstructured":"Krump-Konvalinkova, V. et al. Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells. Arteriosclerosis, thrombosis, and vascular biology 25, 546\u2013552, https:\/\/doi.org\/10.1161\/01.ATV.0000154360.36106.d9 (2005).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"41760_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature reviews. Drug discovery 9, 883\u2013897, https:\/\/doi.org\/10.1038\/nrd3248 (2010).","journal-title":"Nature reviews. Drug discovery"},{"key":"41760_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMct1101691","volume":"366","author":"D Pelletier","year":"2012","unstructured":"Pelletier, D. & Hafler, D. A. Fingolimod for multiple sclerosis. The New England journal of medicine 366, 339\u2013347, https:\/\/doi.org\/10.1056\/NEJMct1101691 (2012).","journal-title":"The New England journal of medicine"},{"key":"41760_CR35","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1016\/j.bmcl.2004.04.070","volume":"14","author":"JJ Hale","year":"2004","unstructured":"Hale, J. J. et al. Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists. Bioorg Med Chem Lett 14, 3501\u20133505, https:\/\/doi.org\/10.1016\/j.bmcl.2004.04.070 (2004).","journal-title":"Bioorg Med Chem Lett"},{"key":"41760_CR36","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvp312","volume":"85","author":"N Takuwa","year":"2010","unstructured":"Takuwa, N. et al. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovascular research 85, 484\u2013493, https:\/\/doi.org\/10.1093\/cvr\/cvp312 (2010).","journal-title":"Cardiovascular research"},{"key":"41760_CR37","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nature06663","volume":"452","author":"F Niessen","year":"2008","unstructured":"Niessen, F. et al. Dendritic cell PAR1-S1P3 signaling couples coagulation and inflammation. Nature 452, 654\u2013658, https:\/\/doi.org\/10.1038\/nature06663 (2008).","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1038\/s41598-023-34694-8","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"record-id":"44378"},{"DOI":"10.1038\/s41598-020-69835-w","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000},"record-id":"44380"},{"DOI":"10.1038\/s41598-020-69835-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T00:00:00Z","timestamp":1595894400000}},{"DOI":"10.1038\/s41598-023-34694-8","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41760-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T14:05:20Z","timestamp":1683900320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41760-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41760"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41760-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"13 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-34694-8","URL":"https:\/\/doi.org\/10.1038\/s41598-023-34694-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2020","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-020-69835-w","URL":"https:\/\/doi.org\/10.1038\/s41598-020-69835-w","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5272"}}